Gujarat Kidney And Super Speciality Limited (GKSL) — Board Meeting

📢 Key Event
Board approved FY2026 audited financials and auditor appointments pending shareholder vote

🔄 What Changed
Unmodified auditor reports confirmed; internal auditor appointed for FY2026-27; secretarial auditor reappointed for five years

🔮 What's Next
None

💡 Investor Takeaway
Shareholders must approve auditor appointments, but financial results show strong cash generation and profitability.

The board approved audited FY2026 standalone financials showing total assets of ₹26,607.67 lakhs, total equity of ₹24,645.86 lakhs, and EPS of [amount context mismatch], alongside unmodified auditor reports and appointments of internal and secretarial auditors for five years pending shareholder approval. The filing also disclosed unaudited quarterly cash flow details with net cash from financing activities of ₹22,693.92 lakhs driving a ₹571.75 lakhs cash increase, and consolidated results reporting ₹1,681.18 lakhs profit after tax and [amount context mismatch] EPS.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GKSL ✨ Ask AI About This